Cancer Clinical Trial
— DPCMGOfficial title:
Identify the Obstacles to Early Diagnosis of Cancer in Patients Over 75 Years Old, on an Outpatient Basis
NCT number | NCT04395040 |
Other study ID # | 69HCL19_0731 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | May 8, 2020 |
Est. completion date | October 2, 2020 |
Verified date | June 2021 |
Source | Hospices Civils de Lyon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
A third of cancers are diagnosed in patients over 75 years of age. There are fears of the elderly talking about new symptoms. The doctor may find himself trapped by general symptoms, which can be confused with "normal aging". Some older, younger people have lived in a world where cancer was little talked about, where there was little treatment possible. There is an idea that doctors are not very quick to start curative treatment because they think that the elderly cannot bear it. It is important to differentiate screening and early diagnosis. Delayed treatment causes a decrease in survival and quality of life. Cancer can be discovered suddenly: for example, occlusion with peritonitis in case of a stenosing colonic tumor, leading to urgent management. The elderly are often excluded from clinical studies. In addition, the geriatric population is heterogeneous, leading to very diverse and individual care, with prioritization of issues. Oncogeriatrics, which combines two services (oncology and geriatrics), is a specialized discipline, promoting comprehensive care for the elderly patient with cancer. The general practitioner is at the center of care. It detects early signs and starts examinations if necessary. Cancer care can be divided up with the different stages of care with various teams, including organ specialists. The general practitioner is the privileged interlocutor for the patient and their family (medico-psycho-social plan), who knows their history and their experience.
Status | Completed |
Enrollment | 16 |
Est. completion date | October 2, 2020 |
Est. primary completion date | October 2, 2020 |
Accepts healthy volunteers | |
Gender | All |
Age group | 75 Years and older |
Eligibility | Inclusion Criteria: - Patients over 75 years old (terminal included) - Incident diagnosis - Has cancer whose diagnosis dates back more than 3 months - Digestive cancer, breast cancer - Stage of advanced cancer (TNM stage: T> T2 (terminal included), M1) - According to the opinion of the oncogeriatrician on the time of taking charge - Follow-up of a geriatrics service, onco-geriatrics orientation - Living in the Rhône department - Non-opposition of the patient to the study Exclusion Criteria: - Cancer diagnosis more than 6 months old - Patient denies |
Country | Name | City | State |
---|---|---|---|
France | Centre Léon Bérard | Lyon | |
France | Hôpital Lyon Sud | Pierre-Bénite | |
France | Centre hospitalier Fleyriat | Viriat |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Identify the obstacles to the early diagnosis of cancer in patients over 75 years old suffering from cancer. | Explore, during a semi-structured interview with the patient, the brakes and levers:
related to the patient linked to the doctor: felt on the practices of health professionals, paternalistic, patient-centered approach linked to the disease: symptoms, acceptance of examinations, acceptance of diagnosis linked to society |
1 hour |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|